The Bangladeshi pharmaceutical industry has seen impressive growth in recent years, and new data highlights the dominance of gastrological drugs in this surge. In FY 2023–24 alone, just five top-selling gastrological drugs generated an astonishing ৳2,392 crore in domestic sales.
This is an excellent development for a country like Bangladesh, whose pharmaceutical market was valued at ৳20,512 crore (BDT 205.12 billion) in 2018. It’s worth noting that this market estimate excludes homeopathic, unani, ayurvedic, and herbal medicines as per the IQVIA & Renowned Newspaper report
Top 5 Gastrological Medicine Brands Sold in Bangladesh (FY 2023–24)
| Brang Name | Manufacture Name | Generic Name | Annul Sold 2024 | Market Share |
| Sergel | Healthcare Pharmaceuticals Ltd | Esomeprazole | 918cr + | 2.67 % |
| Maxpro | Renata | Esomeprazole | 486cr + | 1.41 % |
| Pantonix | Incepta Pharmaceuticals Ltd. | Pantoprazole | 376cr + | 1.10% |
| Napa | Beximco Pharmaceuticals Ltd | Paracetamol | 338cr + | Unknown |
| Cef-3 | Square Pharmaceuticals | Cephalosporin | 274cr + | Unknown |
Sources: IQVIA Bangladesh Reports [Source – 1, Source – 2, Source – 3]
Gastric Medicine Market Share in Bangladesh
- Sergel leads with a 2.67% market share, selling over ৳918 crore of medicine in just nine months.
- Maxpro holds a 1.41% share, while Pantonix commands 1.10% of the market.
- Though primarily used for fever and pain, Napa ranked fourth with ৳338 crore sales.
- Cef-3 also made the list, crossing the ৳274 crore mark.
Other notable brands with over ৳200 crore in sales include:
- Monas
- Exium
- Seclo
- Bizoran
| Category | Market Share | Top Brands | Growth Rate |
| Gastrointestinal | 22% | Sergel, Omee, Nexum, Panton | 12% CAGR |
| Antibiotics | 19% | Cef-3, Meronem, Metrozole | 8% CAGR |
| Cardiovascular | 15% | Cardipro, Lipirex, Starpress | 10% CAGR |
| Pain & Fever | 12% | Napa, Ace, Flexi | 6% CAGR |
| Diabetes | 9% | Diabex, Gluconil, Insuject | 14% CAGR |
Order Genuine Medicine From Healthx
Why Are These Drugs Selling So Well?
Most leading pharmaceutical companies in Bangladesh manufacture medicines using identical molecular compositions. However, a few brands dominate due to consumer trust, driven by consistent results and word-of-mouth marketing.
Key reasons behind the growing demand for gastrological drugs:
- Poor dietary habits and irregular food intake.
- Rise in ulcers, GERD (gastroesophageal reflux disease), and hyperacidity.
- Increased awareness and affordability of generic medicine.
- Urban lifestyle stress and rising cardiovascular issues are fueling interest in cholesterol-lowering drugs like rosuvastatin.
Even in developed nations, the demand for such gastrointestinal and heart-related drugs continues to rise, suggesting global potential for Bangladeshi manufacturers.
Economic Impact of the Pharmaceutical Industry
According to the Bangladesh Bureau of Statistics, the pharmaceutical sector contributed 1.83% to GDP in 2017–18. It remains the second largest contributor to the national exchequer, thanks to:
- A restrictive import policy protects local manufacturers.
- High domestic demand across urban and rural populations.
Final Thoughts
The gastrological drug market in Bangladesh is booming and is led by trusted brands like Sergel, Maxpro, and Pantonix. As chronic health issues rise and healthcare access improves, this sector will grow faster in the coming years.
🏥 HealthX Tip: For affordable online doctor consultations, medicine delivery, and access to trusted gastrological specialists in Dhaka, visit HealthX — your one-stop healthcare platform in Bangladesh.
